Literature DB >> 11771529

Eosinophilia as a side-effect of methotrexate in patients with chronic arthritis.

H A Savolainen1, M Leirisalo-Repo.   

Abstract

This report describes isolated reversible eosinophilia without additional subjective symptoms or signs in three patients on methotrexate therapy, two of them with juvenile idiopathic arthritis and one with rheumatoid arthritis.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11771529     DOI： 10.1007/pl00011213

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  4 in total

1.  Persistent eosinophilia in rheumatoid arthritis: a prospective observational study.

Authors:  Dantis Emmanuel; Subhash Chandra Parija; Ankit Jain; Durga Prasanna Misra; Rakhee Kar; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2018-11-13       Impact factor: 2.631

Review 2.  Rheumatologic disease with peripheral eosinophilia.

Authors:  Nüket Bavbek; Ayşe Kargili; Handan Cipil; Ali Koşar; Yaşar Karaaslan
Journal:  Rheumatol Int       Date:  2004-04-20       Impact factor: 2.631

3.  Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin.

Authors:  Emily M King; Ronit Mazor; Nicolas Çuburu; Ira Pastan
Journal:  J Immunol       Date:  2018-02-05       Impact factor: 5.426

Review 4.  Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort.

Authors:  Dewi Guellec; Morgane Milin; Divi Cornec; Gabriel J Tobon; Thierry Marhadour; Sandrine Jousse-Joulin; Gilles Chiocchia; Olivier Vittecocq; Valérie Devauchelle-Pensec; Alain Saraux
Journal:  RMD Open       Date:  2015-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.